c-MET Protein, Human, Recombinant (ECD, His Tag)

c-MET Protein, Human, Recombinant (ECD, His Tag): 製品情報

> 90 % as determined by SDS-PAGE
< 1.0 EU per μg of the protein as determined by the LAL method
Immobilized Cynomolgus HGF(Cat:90286-CNAH) at 2 μg/mL (100 μL/well) can bind Human c-MET His(Cat:10692-H08H), the EC50 of Human c-MET His(Cat:10692-H08H) is 20-120ng/mL.
A DNA sequence encoding the extracellular domain of human c-Met (NP_000236.2) (Met1-Thr932) was fused with a polyhistidine tag at the C-terminus.
NP No.
HEK293 Cells
Glu 25
The mature form of recombinant human c-Met is a disulfide-linked heterodimer composed of proteolytically cleaved α and β subunits. Each α and β subunit together consists of 919 amino acids and has a predicted molecular mass of 103 (α=33 +β=70) kDa. As a result of glycosylation, rh c-MET heterodimer thus migrates with apparent molecular mass of approximately 45 kDa and 85 kDa respectively in SDS-PAGE under reducing conditions.
Lyophilized from sterile 20mM Tris, 150mM NaCl, pH8.5
Please contact us for any concerns or special requirements.
Normally 5 % - 8 % trehalose, mannitol and 0.01% Tween80 are added as protectants before lyophilization.
Please refer to the specific buffer information in the hard copy of CoA.
In general, recombinant proteins are provided as lyophilized powder which are shipped at ambient temperature.
Bulk packages of recombinant proteins are provided as frozen liquid. They are shipped out with blue ice unless customers require otherwise.
安定性 & 保存条件
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃
Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
A hardcopy of COA with reconstitution instruction is sent along with the products. Please refer to it for detailed information.

c-MET Protein, Human, Recombinant (ECD, His Tag): 画像

Immobilized Cynomolgus HGF(Cat:90286-CNAH) at 2 μg/mL (100 μL/well) can bind Human c-MET His(Cat:10692-H08H), the EC50 of Human c-MET His(Cat:10692-H08H) is 20-120ng/mL.

c-MET Protein, Human, Recombinant (ECD, His Tag): 別名

AUTS9 Protein, Human; c-Met Protein, Human; DFNB97 Protein, Human; HGFR Protein, Human; RCCP2 Protein, Human

c-MET 背景情報

Hepatocyte growth factor receptor (HGFR), also known as c-Met or mesenchymal-epithelial transition factor (MET), is a receptor tyrosine kinase (RTK) that is overexpressed and/or mutated in a variety of malignancies. HGFR protein is produced as a single-chain precursor, and HGF is the only known ligand. Normal HGF/HGFR signaling is essential for embryonic development, tissue repair, or wound healing, whereas aberrantly active HGFR has been strongly implicated in tumorigenesis, particularly in the development of invasive and metastatic phenotypes. HGFR protein is a multifaceted regulator of growth, motility, and invasion, and is normally expressed by cells of epithelial origin. Preclinical studies suggest that targeting aberrant HGFR signaling could be an attractive therapy in cancer.
MET proto-oncogene, receptor tyrosine kinase
  • McGill GG, et al. (2006) c-Met expression is regulated by Mitf in the melanocyte lineage. J Biol Chem. 281(15): 10365-73.
  • Garcia S, et al. (2007) c-Met overexpression in inflammatory breast carcinomas: automated quantification on tissue microarrays. British journal of cancer. 96(2): 329-35.
  • Socoteanu MP, et al. (2008) c-Met targeted therapy of cholangiocarcinoma. World J Gastroenterol. 14(19): 2990-4.
  • Kong DS, et al. (2009) Prognostic significance of c-Met expression in glioblastomas. Cancer. 115(1): 140-8.
  • Anti-MET immunoPET for non-small cell lung cancer using fully human antibody fragments
    Li, K;Tavare, R;Zettlitz, KA;Mumenthaler, SM;Mallick, P;Zhou, Y;Marks, JD;Wu, AM;
    Mol. Cancer Ther.
    Phage library selection
  • Detection of colonic neoplasia in vivo using near-infrared-labeled peptide targeting cMet
    Wu, X;Zhou, J;Wang, F;Meng, X;Chen, J;Chang, TS;Lee, M;Li, G;Li, X;Appelman, HD;Kuick, R;Wang, TD;
    Sci Rep
  • Dual-function chimeric antigen receptor T cells targeting c-Met and PD-1 exhibit potent anti-tumor efficacy in solid tumors
    Yuan, X;Sun, Z;Yuan, Q;Hou, W;Liang, Q;Wang, Y;Mo, W;Wang, H;Yu, M;
    Invest New Drugs
カートに追加しました カートに追加しませんでした カートを更新しています。少々お待ちください U.S.A.